JD Supra: Mergers

SEPTEMBER 26, 2024

The California Legislature recently passed Assembly Bill 3129 (“AB 3129” or the “Bill”), which, if signed by California Governor Gavin Newsom, would increase oversight of healthcare entity transactions involving private equity investment. Governor Newsom has until September 30, 2024, to sign or veto the Bill.

Private Equity 175

Private Equity Healthcare Equities Investment 175

JD Supra: Mergers

AUGUST 1, 2024

Over the last decade, private equity firms have acquired healthcare companies, hospitals, and clinics at an increasing rate. In fact, in those ten years, private equity firms have spent roughly $1 trillion on an estimated 8,000 healthcare deals. This trend is only expected to increase through 2024.

Private Equity 157

Private Equity Healthcare Equities Portfolio 157

JD Supra: Mergers

MAY 22, 2024

McGuireWoods recently held its 20th Annual Healthcare Private Equity and Finance Conference (HCPE Conference) in Chicago. The premier, two-day conference held May 8-9, 2024, provided content-rich programming that explored the economic and legislative environments, approaches for.

Private Equity 163

Private Equity Healthcare Finance Finance 163

JD Supra: Mergers

OCTOBER 11, 2024

State legislatures across the country are beginning to consider and debate the pros and cons of passing laws aimed at regulating private equity’s role in the healthcare industry. Originally published in The Journal Record - October 10, 2024. By: McAfee & Taft

Private Equity 175

Private Equity Healthcare Equities 175

JD Supra: Mergers

AUGUST 15, 2024

healthcare industry has weathered the storm over the past couple of years, we may be reaching calmer waters in the coming months. private equity investors has reached an all-time high, and with capital on the sideline ready to deploy, pressure to get deals done is on the rise. Although the U.S. Dry powder held by U.S.

Private Equity 175

Private Equity Healthcare Equities M&A 175

JD Supra: Mergers

JANUARY 10, 2025

As some packed the skis and headed to their favorite slopes this winter season, it is hard not to see the analogies to the healthcare private equity (PE) transaction market as we ring in the New Year. Much like the Northern Rockies, there should be plenty of dry powder to support a robust dealmaking environment in 2025.

Private Equity 163

Private Equity Healthcare Equities IT 163

JD Supra: Mergers

MARCH 12, 2024

Private equity acquisitions in healthcare will likely face increased scrutiny from multiple federal departments, as well as from state antitrust enforcement officials. By: Mayer Brown

Private Equity 180

Private Equity Healthcare Equities Acquisitions 180

JD Supra: Mergers

FEBRUARY 26, 2025

Private equity (PE) investment in the U.S. healthcare sector faces a complex and evolving regulatory and legislative landscape. Both federal and state authorities are intensifying scrutiny of PE investment, driven by concerns about market consolidation, quality of care, corporate profiteering and lack of financial transparency.

Private Equity 185

Private Equity Healthcare Equities Investment 185

JD Supra: Mergers

OCTOBER 1, 2024

Gavin Newsom vetoed a controversial bill that would have restricted private equity and hedge fund healthcare transactions in the state. On Saturday, September 28, California Gov. By: Fenwick & West LLP

Private Equity 163

Private Equity Healthcare Equities Funds 163

JD Supra: Mergers

AUGUST 5, 2024

The Massachusetts legislative session for 2024 has come to a close without the passage of a bill that would have targeted private equity in healthcare.

Private Equity 169

Private Equity Healthcare Equities Funds 169

JD Supra: Mergers

JULY 25, 2024

2871, An Act Enhancing the Health Care Market Review Process (the Bill), to increase oversight of healthcare transactions involving private equity firms, real estate investment trusts, and management services organizations (MSOs). On July 18, 2024, the Massachusetts Senate passed S.

Private Equity 169

Private Equity Healthcare Equities Management 169

JD Supra: Mergers

AUGUST 13, 2024

A recent wave of state legislation is changing the course of healthcare transactions, and organizations (particularly private equity-backed organizations) that engage in mergers and acquisitions in the healthcare industry should prepare for increased scrutiny. By: BakerHostetler

Private Equity 169

Private Equity Healthcare Equities Mergers and Acquisitions 169

JD Supra: Mergers

JANUARY 14, 2025

Among various other healthcare market oversight enhancements, the Act expands the authority of the Massachusetts Attorney General, Center for Health Information and Analysis (CHIA), and Health Policy Commission (HPC) to review and gather data regarding private equity investment into healthcare providers and healthcare management companies.

Private Equity 157

Private Equity Healthcare Equities Management 157

JD Supra: Mergers

SEPTEMBER 23, 2024

On August 31, the last day of its 2024 Legislative Session, the California Legislature approved Assembly Bill 3129 (Wood), which provides for notification to and review by the Attorney General of health care transactions involving private equity groups and hedge funds.

Private Equity 169

Private Equity Equities Healthcare Funds 169

JD Supra: Mergers

AUGUST 15, 2024

California’s Senate Appropriations Committee will hold a hearing on California’s private equity bill, AB 3129, on August 15, 2024. This proposed legislation would expand existing California Attorney General authority to include review and approval authority over most healthcare private equity transactions.

Private Equity 180

Private Equity Equities Healthcare 180

JD Supra: Mergers

OCTOBER 1, 2024

The Bill, if enacted, would have imposed new notice and consent requirements for private equity investors involved in healthcare transactions. On September 28, 2024, California Governor Gavin Newsom vetoed California Assembly Bill 3129 (the Bill). By: Robinson+Cole Health Law Diagnosis

Private Equity 163

Private Equity Healthcare Equities Investors 163

JD Supra: Mergers

MARCH 12, 2024

On March 5, the FTC convened a workshop with regulators, academics and stakeholders to discuss the impact of private equity in the healthcare market. The workshop reflects the FTC and DOJ Antitrust Division’s recent focus on private equity and serial roll-up transactions more broadly as targets for antitrust enforcement.

Private Equity 169

Private Equity Healthcare Equities Acquisitions 169

JD Supra: Mergers

JUNE 13, 2024

By: Holland & Knight LLP

Private Equity 163

Private Equity Healthcare Equities Funds 163

JD Supra: Mergers

JANUARY 14, 2025

The bill seeks to strengthen oversight of private equity investment within Massachusetts healthcare sector and enforce stricter penalties for noncompliance with reporting requirements and the state False Claims Act (FCA). 5159), and Governor Maura Healey signed it on January 8, 2025. By: McDermott Will & Emery

Private Equity 157

Private Equity Healthcare Equities Investment 157

JD Supra: Mergers

JUNE 12, 2024

Department of Health and Human Services’ (together the “Agencies”) request for information regarding consolidation in healthcare by private equity. Department of Justice, and the U.S. By: Sheppard Mullin Richter & Hampton LLP

Private Equity 169

Private Equity Healthcare Equities Trading 169

JD Supra: Mergers

MARCH 15, 2024

From the West Coast Healthcare Desk is an ongoing series of Holland & Knight Healthcare Blog articles and alerts focused on healthcare industry developments and points of interest in the West Coast healthcare marketplace.

Healthcare 175

Healthcare Private Equity Equities 175

JD Supra: Mergers

SEPTEMBER 5, 2024

AB 3129 would establish a mandatory approval process for a broad range of healthcare-related transactions involving private equity funds and hedge funds, giving the California Attorney General (“CA AG”) broad authority to block or impose restrictions on transactions to protect public interest.

Private Equity 175

Private Equity Healthcare Funds Equities 175

JD Supra: Mergers

MARCH 8, 2024

WindRose Health Investors has announced its acquisition of CardioOne. CardioOne, founded in 2023 and based in Houston, is a management services partner and technology platform designed for independent cardiology practices. By: McGuireWoods LLP

Private Equity 267

Private Equity Healthcare Equities Investors 267

JD Supra: Mergers

JUNE 3, 2024

California’s AB 3219, which would require private equity firms and hedge funds to obtain prior approval to consummate certain healthcare-related transactions, is now one step closer to becoming law following the State Assembly’s May 22, 2024 passage of the pending legislation.

Private Equity 169

Private Equity Healthcare Equities Funds 169

JD Supra: Mergers

DECEMBER 13, 2024

Episode 12: Exploring Consolidation and Private Equity Investment in Physician Practice Management - In this episode of BRight Minds in Healthcare Delivery, host Eric Tower interviews Robert Aprill, a partner at Physician Growth Partners. By: Blank Rome LLP

Private Equity 163

Private Equity Equities Investment Management 163

JD Supra: Mergers

OCTOBER 2, 2024

3129 (AB 3129), which would have required private equity groups and hedge funds to obtain the Attorney General’s written consent at least 90 days prior to acquisitions or changes of control of certain health care facilities, provider groups, and other providers. On September 28, 2024, Governor Newsom vetoed Assembly Bill No.

Private Equity 169

Private Equity Equities Healthcare Funds 169

JD Supra: Mergers

MAY 21, 2024

Earlier this year, Indiana joined a growing number of states by enacting a new notification requirement for certain healthcare transactions.

Healthcare 190

Healthcare Private Equity Equities Investors 190

JD Supra: Mergers

FEBRUARY 13, 2025

Nautic Partners has acquired Proud Moments ABA from Audax Private Equity, according to a news release. Proud Moments, founded in 2014 and based in Brooklyn, New York, is a national provider of applied behavioral analysis (ABA) therapy to children and young adults with autism spectrum disorder. By: McGuireWoods LLP

Private Equity 169

Private Equity Equities Healthcare 169

JD Supra: Mergers

DECEMBER 29, 2023

13, 2023, the White House announced new efforts to lower healthcare and prescription drug costs, issuing a detailed Fact Sheet. Two of the initiatives focus on private equity investments in healthcare. White House and Agency Initiatives - On Dec. By: McGuireWoods LLP

Private Equity 163

Private Equity Healthcare Equities Investment 163

JD Supra: Mergers

JANUARY 16, 2025

Machinify, founded in 2016 and based in Palo Alto, California, is a provider of artificial intelligence (AI)-powered software focused on healthcare claims and payments. New Mountain Capital has announced it will acquire Machinify. By: McGuireWoods LLP

Healthcare 175

Healthcare Private Equity Equities Capital 175

JD Supra: Mergers

MARCH 8, 2024

A recent government initiative announced on March 5, 2024 signals that more antitrust scrutiny for private equity firms and asset managers is on the horizon. By: Paul Hastings LLP

Private Equity 163

Private Equity Equities Healthcare Asset Management 163

JD Supra: Mergers

JULY 17, 2024

Deal volume across the healthcare industry generally appears to have steadied despite headwinds. The general sentiment is that buyers have adapted to the current interest rates and are gritting their teeth and pressing forward—especially private equity (PE) investors who need to deploy their “dry powder.”.

Healthcare 190

Healthcare Private Equity Equities Investors 190

JD Supra: Mergers

MARCH 11, 2025

WBA (NASDAQ: WBA), based in Deerfield, Illinois, is an integrated healthcare, pharmacy and retail company. Sycamore Partners will acquire Walgreens Boots Alliance (WBA), according to a news release. By: McGuireWoods LLP

Healthcare 150

Healthcare Private Equity Equities Retail 150

JD Supra: Mergers

JUNE 12, 2024

Episode 7: Exploring the Role of Operating Partners in Private Equity In this episode of BRight Minds in Healthcare Delivery, Donna Cooper joins host Eric Tower for a conversation about her career and how her prior experience has influenced her current role as an operating partner. By: Blank Rome LLP

Private Equity 163

Private Equity Equities Healthcare 163

JD Supra: Mergers

MAY 9, 2024

Knox Lane has announced the acquisition of All Star Healthcare Solutions. By: McGuireWoods LLP

Healthcare 150

Healthcare Private Equity Hospitality Equities 150

JD Supra: Mergers

JULY 2, 2024

Triton Pacific Healthcare Partners has announced the closing of its sale of BioMatrix Specialty Infusion Pharmacy to Frazier Healthcare Partners. BioMatrix, founded in 2001 and based in Plantation, Florida, is a provider of specialty infusion services in the United States. By: McGuireWoods LLP

Healthcare 150

Healthcare Private Equity Equities Sale 150

JD Supra: Mergers

AUGUST 29, 2024

Audax Private Equity has announced it will acquire the clinical services business of Avantor (NYSE: AVTR). By: McGuireWoods LLP

Private Equity 150

Private Equity Equities Healthcare Business 150